key: cord-0032283-aeslvm26
authors: Betchen, Melanie; Giovinco, Holly M.; Curry, Michael; Luu, Jackson; Fraimow, Henry; Carabetta, Valerie J.; Nahra, Raquel
title: Evaluating the Effectiveness of Hospital Antiseptics on Multidrug-Resistant Acinetobacter baumannii: Understanding the Relationship between Microbicide and Antibiotic Resistance
date: 2022-05-03
journal: Antibiotics (Basel)
DOI: 10.3390/antibiotics11050614
sha: c0be02465810d6d9c431db83fc3711d6bda5c898
doc_id: 32283
cord_uid: aeslvm26

Acinetobacter baumannii hospital infections are difficult to treat due to the rapid emergence of multidrug-resistant (MDR) strains. In addition, A. baumannii can survive in numerous adverse environments, including in the presence of common hospital antiseptics. We hypothesized that in addition to accumulating drug resistance determinants, MDR A. baumannii strains also accumulate mutations that allow for greater microbicide tolerance when compared to pan-susceptible (PS) strains. To test this hypothesis, we compared the survival of five MDR and five PS patient isolates when exposed to bleach, ethanol, quaternary ammonium compounds, chlorhexidine gluconate, and povidone. We evaluated bacteria in a free-living planktonic state and under biofilm conditions. Each disinfectant eliminated 99.9% of planktonic bacteria, but this was not the case for bacterial biofilms. Next, we characterized strains for the presence of the known microbicide-resistance genes cepA, qacEΔ1, qacE, and qacA. MDR strains did not survive more than PS strains in the presence of microbicides, but microbicide-resistant strains had higher survival rates under some conditions. Interestingly, the PS strains were more likely to possess microbicide-resistance genes. Microbicide resistance remains an important topic in healthcare and may be independent of antimicrobial resistance. Hospitals should consider stricter isolation precautions that take pan-susceptible strains into account.

Hospital-acquired infections (HAIs), especially those from Gram-negative organisms that tend to become multidrug resistant (MDR), pose serious threats to healthcare systems [1] . Acinetobacter baumannii is a non-spore forming, Gram-negative rod that is ubiquitous in the environment, and an opportunistic human pathogen. A. baumannii infections commonly occur in severely ill patients with extended hospital stays. These bacteria readily acquire antibiotic resistance, resulting in difficult to treat infections which may require higher doses and longer treatment durations of more toxic antibiotics [2] [3] [4] [5] . A. baumannii is one of the five pathogens labeled as an urgent threat by the Centers for Disease Control and Prevention (CDC), due to its ability to become resistant to multiple standard-of-care antibiotics [6] . In fact, roughly 50% of A. baumannii isolates are MDR [7] . The mechanisms of resistance found in this bacterium include the presence of beta lactamases, mutation of target sites, changes in membrane permeability, and biofilms are also inherently more drug-tolerant, some newer technologies are being explored as alternative therapeutics, including silver nano-particles [30] . In a promising study, nanoparticles were shown to reduce biofilm formation and downregulate the expression of biofilm producing genes among A. baumannii wound isolates [31] . However, evaluation of safety and efficacy is still underway [30] . Acinetobacter biofilms remain challenging to eradicate from surfaces and such infections are still difficult to treat.

The mechanism of action for each antiseptic agent varies. The mechanism of action for ethanol, CHG, and quaternary ammonium compounds (QACs) is the degradation of cell membranes [32] , resulting in cell lysis and further leading to the degradation of cellular proteins and enzymes [33] . Bleach is a potent oxidizer and disrupts cellular activities, such as protein synthesis. The skin antiseptic povidone rapidly degrades proteins [32] . Resistance may emerge when an agent is used at a sub-lethal concentration, or for an inappropriate amount of time [34] . The overproduction of certain efflux pumps is a mechanism of microbicide resistance employed by bacterial pathogens [33] . The QACspecific efflux pumps are members of the small multidrug-resistance (SMR) family [35] , and many of the mechanisms that lead to antibiotic resistance, coincide with the mechanisms of microbicide resistance [5, 34, 36] . For example, the qacE efflux pump gene is commonly found on integrons with the sul1 gene, which confers resistance to sulfonamides [35] . Furthermore, the presence of qacE∆1 and qacE has been correlated with the presence of certain beta-lactamase genes (bla VIM and bla NDM-1 ) and has additionally been associated with tolerance to CHG [5] . CepA is an efflux pump that increases the MICs of Klebsiella pneumoniae after exposure to CHG [32, 37] . While the qacA gene is frequently seen among Gram-positive pathogens [38] , a recent study of 44 A. baumannii isolates in Saudi Arabia revealed that 16.7% of strains contained the qacA gene [39] .

The role that microbicide-resistance genes play in hospital outbreaks remains controversial. One study reported that the qacE and qacE∆1 genes were identified among 100 MDR A. baumannii isolates from an ICU, however no evidence of microbicide tolerance was identified [40] . In agreement, a different study found no differences in bacterial survival among 20 MDR strains and 20 sporadic pan-susceptible strains after exposure to antiseptics [41] . Furthermore, there was no significant correlation between the presence of cepA, qacE, and qacE∆1 genes and an increased MIC among 44 MDR A. baumannii, Pseudomonas aeruginosa, and K. pneumoniae strains [39] . However, another study found that A. baumannii strains that were resistant to carbapenems, fluoroquinolones, aminoglycosides, and tetracyclines were associated with microbicide tolerance [42] .

Hospitals routinely use a variety of disinfecting agents, such as QACs, bleach, and ethanol. These are usually in the form of hospital disinfectant wipes and are used to clean surfaces and medical equipment. Antiseptics such as 10% povidone and 2% CHG are also commonly used for hand hygiene. For antiseptics to be effective against bacteria they must be used at specific contact or dwell times and meet certain Food and Drug Administration (FDA) standards. In general, this requires the germicide to kill 99.9% of bacteria on a hard, non-porous surface after a maximum time of 5 min [43] . Different disinfectant wipes require different dwell times. Sani-cloth ® wipes containing bleach are considered bactericidal, viricidal, and fungicidal when a dwell time of 4 min is used. However, the efficacy against certain pathogens varies based on dwell time [44] . At 1 min, it is effective against A. baumannii isolates that are resistant to cefazolin, ampicillin, gentamicin, piperacillin, trimethoprim-sulfamethoxazole, and intermediately resistant to cefotaxime and ceftriaxone, but not necessarily carbapenem-resistant A. baumannii [44] . Furthermore, while it is effective against A. baumannii after 1 min, it is not effective against all pathogens until after 4 min of disinfection [44] . Ethanol typically has a dwell time of 30 s to 1 min [45] . QAC wipes have different dwell times depending on the components. 0.61% dodecyl dimethyl ammonium chloride in 27% ethanol and 25% isopropanol (0.61% DDAC) is used mainly in the ICU and has a dwell time of 1 min [46] , whereas the combination QAC wipe of 0.25% alkyl dimethyl ethyl benzyl ammonium chloride, 0.25% alkyl dimethyl benzyl ammonium chloride in 55% isopropanol (0.50% BAC) has a dwell time of 2 min [47] .

Most of the research performed so far on microbicide tolerance or resistance among A. baumannii isolates are performed under optimal settings with microbicides used at the proper dwell times. Therefore, a possible reason for hospital outbreaks of multidrug-resistant organisms could be due to improper cleaning techniques. Our goal is to explore the interaction of MDR bacteria with microbicides as potential contributors to hospital outbreaks. We hypothesized that in addition to accumulating drug-resistance determinants, MDR A. baumannii also accumulates mutations that allow for greater antiseptic tolerance when compared to pan-susceptible (PS) strains. We found no significant differences between MDR and PS strain survival among planktonic bacteria. As we did not find significant differences between MDR and PS strains under planktonic conditions, we tested the efficacy of antiseptic agents against bacterial biofilms. Our results demonstrated increased bacterial survival, but no differences between MDR and PS strains. Finally, we determined which strains contained the known microbicide-resistance genes and showed that significantly more microbicide-resistant bacteria survived compared to microbicide-sensitive bacteria after specific treatments. Interestingly, we found that the presence of microbicide-resistance genes was more likely in PS strains. This suggests that PS A. baumannii may be underestimated in the propagation of hospital outbreaks and highlights the need for increased hospital precautions for dealing with the spread of both MDR and PS organisms.

A. baumannii has evolved to survive and persist in harsh environments [4, 12, [20] [21] [22] [23] [24] , including in the presence of common hospital antiseptics [5, 42] . Hospital outbreaks of A. baumannii are becoming more common, especially among patients in ICUs. We hypothesized that MDR A. baumannii outbreaks occur because these strains are more tolerant or resistant to microbicides than susceptible strains. We thought it possible that some drug-resistance mechanisms may offer cross protection against some antiseptic agents. To test this idea, we performed time kill assays using five MDR and five PS A. baumannii patient isolates, in the presence and absence of various disinfectants and skin antiseptics. Free-living, planktonic A. baumannii strains were exposed to antiseptics for 1, 2 and 4 min, and survivors plated on rich media. Every antiseptic agent tested killed >99% of either MDR or PS bacteria. The most efficacious antiseptics were the QAC's, and the skin antiseptics CHG and povidone, which completely eradicated all bacteria (Table S1 ). For 0.63% bleach, 55% and 70% ethanol, a small subpopulation (<1%) of bacteria survived treatment, even beyond the recommended dwell times ( Figure 1A -C, Tables S1 and S2). There were no statistical differences among the three treatments ( Figure 1D ). To determine if the MDR strains survived better than the PS strains, we performed unpaired t- There were no statistical differences among the three treatments ( Figure 1D ). To determine if the MDR strains survived better than the PS strains, we performed unpaired t-tests among the two separate groups ( Figure 2 ). Again, no statistical differences were observed between any of the three antiseptics, when used at their proper dwell times. Our results suggest that the drug-resistance properties of the bacterial strains do not directly confer increased survival in the presence of common hospital antiseptic agents ( Figure 2 and Table S2 ). There were no statistical differences among the three treatments ( Figure 1D ). To determine if the MDR strains survived better than the PS strains, we performed unpaired ttests among the two separate groups ( Figure 2 ). Again, no statistical differences were observed between any of the three antiseptics, when used at their proper dwell times. Our results suggest that the drug-resistance properties of the bacterial strains do not directly confer increased survival in the presence of common hospital antiseptic agents ( Figure 2 and Table S2 ). 

Since we did not observe any differences between the survival of MDR and PS strains, we checked the strains for the presence of microbicide-resistance genes. Some known microbicide resistance genes have been characterized in A. baumannii [5] . To test for the presence of some common efflux pump genes, including qacA, qacE, qacEΔ1 and 

Since we did not observe any differences between the survival of MDR and PS strains, we checked the strains for the presence of microbicide-resistance genes. Some known microbicide resistance genes have been characterized in A. baumannii [5] . To test for the presence of some common efflux pump genes, including qacA, qacE, qacE∆1 and cepA, we amplified each gene by PCR. All ten strains contained the cepA resistance gene, however only four isolates additionally contained both qacE and qacE∆1. None of the isolates contained the qacA gene (Table 1) . Table 1 . Distribution of known microbicide-resistance genes among A. baumannii strains.

Resistance Pattern qacA qacE∆1 qacE cepA

We presumed that the presence of three microbicide-resistance genes would lead to more tolerance to microbicides if they were expressed. The strains were grouped as microbicide-sensitive, containing only cepA, and microbicide-resistant, which contained qacE, qacE∆1, and cepA. Bacterial survival was evaluated based on microbicide resistance for each antiseptic using unpaired t-tests ( Figure 3 ). Microbicide-resistant bacteria among planktonic bacteria survived more compared to microbicide-sensitive bacteria after treatment with bleach (p = 0.01) but not after 55% and 70% ethanol. This suggests that the presence of these efflux genes may confer microbicide tolerance to bleach, irrespective of their drug-resistance status.

PS -+ + +

We presumed that the presence of three microbicide-resistance genes would lead to more tolerance to microbicides if they were expressed. The strains were grouped as microbicide-sensitive, containing only cepA, and microbicide-resistant, which contained qacE, qacEΔ1, and cepA. Bacterial survival was evaluated based on microbicide resistance for each antiseptic using unpaired t-tests ( Figure 3 ). Microbicide-resistant bacteria among planktonic bacteria survived more compared to microbicide-sensitive bacteria after treatment with bleach (p = 0.01) but not after 55% and 70% ethanol. This suggests that the presence of these efflux genes may confer microbicide tolerance to bleach, irrespective of their drug-resistance status. 

Although the MDR strains were not found to be more resistant to the clinical disinfecting agents than susceptible strains, it is possible that they have an increased MIC or MBC. To test this idea, we determined the MIC and MBC of the A. baumannii strains to each component of the hospital wipes, including bleach, ethanol, and isopropanol. MIC determination for the QACs was not possible, as at higher concentrations, a precipitate formed that led to an artificially high optical density (OD) reading when no bacterial 

Although the MDR strains were not found to be more resistant to the clinical disinfecting agents than susceptible strains, it is possible that they have an increased MIC or MBC. To test this idea, we determined the MIC and MBC of the A. baumannii strains to each component of the hospital wipes, including bleach, ethanol, and isopropanol. MIC determination for the QACs was not possible, as at higher concentrations, a precipitate formed that led to an artificially high optical density (OD) reading when no bacterial growth was observed by plating. In general, we found that the hospital concentrations used were well above the MICs and MBCs for bleach, ethanol, and isopropanol (Tables 2-4 ). As expected, the MBCs for all microbicides were higher than their respective MICs. Generally, an MBC/MIC ratio >4 indicates that the agent has bacteriostatic properties, while a ratio of <4 indicates the agent is bactericidal [48, 49] . If looking at the average MBC/MIC ratio for all strains, bleach is bactericidal (Table 2) . However, if the strains are separated by drug or microbicide-resistance properties, differences emerge. While the MICs for all groups are very similar, the MBCs for the MDR and microbicide-resistant strains were increased compared to the corresponding sensitive strains ( Table 2 ). The MBC/MIC ratio becomes >4 after bleach treatment for MDR and microbicide-resistant strains, indicating bleach has bacteriostatic properties against these strains. This aligns with our prior time-kill assay results, which showed planktonic microbicide-resistant strains survived more after bleach exposure compared to microbicide-sensitive ones (Figure 3 ). The MBC for the MDR strains in ethanol was increased compared to the PS strains, however, ethanol was still bactericidal against these strains (Table 3) . A similar observation was made for the microbicide-resistant strains with isopropanol ( Table 4 ). The increase in MBC indicates a greater risk for development of microbicide resistance [41] .

Since we did not observe any differences among MDR and PS A. baumannii strains when grown planktonically, we next determined if bacteria that were present in biofilms would demonstrate any differences in microbicide survival. Biofilm formation in A. baumannii is an important virulence factor that allows for survival in adverse environments, including on polycarbonate, which is often used in the production of medical equipment [50] [51] [52] . Bacterial biofilms were formed following static growth in 96-well plates for 48 h. Non-adherent cells were removed, and resulting biofilms were exposed to antiseptic agents for 1, 2 and 4 min. Biofilm metabolic activity was determined using an XTT-reduction assay and used as a proxy to determine biofilm viability after exposure to microbicidal agents. Overall, there was significantly more survival among bacteria in biofilms compared to free living (compare Figure 4 to Figure 1D , Table S3 ). We found that there was 3.7% survival after 4 min of bleach exposure, 6.23% after 1 min of 55% ethanol, and 3.3% after 1 min of 70% ethanol. Whereas previously the QAC formulations led to complete killing of planktonic bacteria, in biofilms there was 2.6% survival after exposure to 1 min of DDAC, and 1.5% after 2 min of exposure of 0.5% BAC (Figure 4 ). Among the different antiseptic treatments, these differences were not significant ( Figure 4 and Table S3 ). Non-adherent cells were removed, and resulting biofilms were exposed to antiseptic agents for 1, 2 and 4 min. Biofilm metabolic activity was determined using an XTT-reduction assay and used as a proxy to determine biofilm viability after exposure to microbicidal agents. Overall, there was significantly more survival among bacteria in biofilms compared to free living (compare Figure 4 to Figure 1D , Table S3 ). We found that there was 3.7% survival after 4 min of bleach exposure, 6.23% after 1 min of 55% ethanol, and 3.3% after 1 min of 70% ethanol. Whereas previously the QAC formulations led to complete killing of planktonic bacteria, in biofilms there was 2.6% survival after exposure to 1 min of DDAC, and 1.5% after 2 min of exposure of 0.5% BAC (Figure 4 ). Among the different antiseptic treatments, these differences were not significant ( Figure 4 and Table S3 ). . Bacterial biofilm survival when exposed to various microbicides. A comparison of average biofilm survival when exposed to various microbicidal agents. No significant differences were observed between all microbicides at their proper contact times (4 min for bleach, 1 min for 55% and 70% ethanol and DDAC, and 2 min for BAC). The average metabolic activity of all strains is displayed; error bars represent standard deviation.

Increasing the contact time did not significantly affect bacterial survival after treatment with 0.63% bleach, 55% ethanol, or 0.50% DDAC ( Figure 5 , Table S4 ). After treatment with 70% ethanol, a small, but significant increase in survival was noted after 2 min (p = 0.04) and 4 min (p = 0.02) compared to 1 min. After treatment with 0.61% BAC, a similar small increase was observed at 2 min (p = 0.0009) and 4 min (p = 0.001) compared to 1 min ( Figure 5D -E and Table S4 ). It is likely that these small observed increases are not biologically significant. . Bacterial biofilm survival when exposed to various microbicides. A comparison of average biofilm survival when exposed to various microbicidal agents. No significant differences were observed between all microbicides at their proper contact times (4 min for bleach, 1 min for 55% and 70% ethanol and DDAC, and 2 min for BAC). The average metabolic activity of all strains is displayed; error bars represent standard deviation.

Increasing the contact time did not significantly affect bacterial survival after treatment with 0.63% bleach, 55% ethanol, or 0.50% DDAC ( Figure 5 , Table S4 ). After treatment with 70% ethanol, a small, but significant increase in survival was noted after 2 min (p = 0.04) and 4 min (p = 0.02) compared to 1 min. After treatment with 0.61% BAC, a similar small increase was observed at 2 min (p = 0.0009) and 4 min (p = 0.001) compared to 1 min ( Figure 5D ,E and Table S4 ). It is likely that these small observed increases are not biologically significant.

Increasing the contact time did not significantly affect bacterial survival after treatment with 0.63% bleach, 55% ethanol, or 0.50% DDAC ( Figure 5, Table S4 ). After treatment with 70% ethanol, a small, but significant increase in survival was noted after 2 min (p = 0.04) and 4 min (p = 0.02) compared to 1 min. After treatment with 0.61% BAC, a similar small increase was observed at 2 min (p = 0.0009) and 4 min (p = 0.001) compared to 1 min ( Figure 5D -E and Table S4 ). It is likely that these small observed increases are not biologically significant. . Of the two QACs tested, no significant differences were seen in (D) 0.5% BAC, and small, but significant differences were observed after (E) 4 min compared to 1 min (p = 0.0009) and 2 min (p = 0.0012) of 0.61% DDAC exposure. The average metabolic activity of all strains is displayed and error bars represent the standard deviation. A p-value of ≤0.05 was considered significant. * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001.

Bacterial biofilm survival was further evaluated based on the resistance pattern in each microbicide (bleach, 55% and 70% ethanol, BAC, and DDAC) using unpaired t-tests. No significant differences were seen between MDR and PS bacterial survival in any of the microbicides after biofilm formation ( Figure 6 ). However, more microbicide-resistant compared to microbicide-sensitive bacteria survived after 55% ethanol treatment ( Figure 7B ). No significant differences were seen between microbicide-resistant and sensitive isolates in other antiseptics (Figure 7 ). Bacterial biofilm survival was further evaluated based on the resistance pattern in each microbicide (bleach, 55% and 70% ethanol, BAC, and DDAC) using unpaired t-tests. No significant differences were seen between MDR and PS bacterial survival in any of the microbicides after biofilm formation ( Figure 6 ). However, more microbicide-resistant compared to microbicide-sensitive bacteria survived after 55% ethanol treatment ( Figure  7B ). No significant differences were seen between microbicide-resistant and sensitive isolates in other antiseptics (Figure 7 ). 

Hospital-acquired infections can be detrimental to a patient's health, and outbreaks can be influenced by a multitude of external factors. From 2012-2018, the number of CRAB infections was downtrending [53] . The hospital rates of carbapenem resistance were approximately 20-35% based on antibiograms, but resistance can vary year to year [54] . Recently, the COVID-19 pandemic resulted in increased CRAB hospital outbreaks [55] [56] [57] , which may be attributable to empiric antibiotic overuse [56] . Given the current crisis of antibiotic resistance, preventing and controlling outbreaks has become more important than ever. Besides practicing antimicrobial stewardship, proper decontamination-a term defined by the Occupational Safety and Health Administration (OSHA) to describe the process by which pathogenic organisms are destroyed either physically or chemicallyshould be employed. This process can be through cleaning, sanitizing, disinfecting, or sterilizing. Cleaning refers to the removal of pathogens using a detergent or surfactant. Sanitizing refers to reducing the number of pathogens within 30 s. Disinfecting refers to the destruction of pathogens, except for sporulating organisms. Sterilizing is the process by which all pathogens are effectively killed, including those that undergo sporulation [26] . The germicidal formulations used in this study mimic hospital disinfectant wipes used by Cooper University Hospital and are approved by the Environmental Protection Agency (EPA) to be effective against specific MDR A. baumannii strains after one a minute exposure of bleach and DDAC, but two minutes for BAC.

The goals of this study were to understand the implications of antibiotic and microbicide-resistance among A. baumannii isolates and to assess their potential contribution to hospital outbreaks. We selected disinfecting wipes and skin antiseptics that are routinely 

Hospital-acquired infections can be detrimental to a patient's health, and outbreaks can be influenced by a multitude of external factors. From 2012-2018, the number of CRAB infections was downtrending [53] . The hospital rates of carbapenem resistance were approximately 20-35% based on antibiograms, but resistance can vary year to year [54] . Recently, the COVID-19 pandemic resulted in increased CRAB hospital outbreaks [55] [56] [57] , which may be attributable to empiric antibiotic overuse [56] . Given the current crisis of antibiotic resistance, preventing and controlling outbreaks has become more important than ever. Besides practicing antimicrobial stewardship, proper decontamination-a term defined by the Occupational Safety and Health Administration (OSHA) to describe the process by which pathogenic organisms are destroyed either physically or chemically-should be employed. This process can be through cleaning, sanitizing, disinfecting, or sterilizing. Cleaning refers to the removal of pathogens using a detergent or surfactant. Sanitizing refers to reducing the number of pathogens within 30 s. Disinfecting refers to the destruction of pathogens, except for sporulating organisms. Sterilizing is the process by which all pathogens are effectively killed, including those that undergo sporulation [26] . The germicidal formulations used in this study mimic hospital disinfectant wipes used by Cooper University Hospital and are approved by the Environmental Protection Agency (EPA) to be effective against specific MDR A. baumannii strains after one a minute exposure of bleach and DDAC, but two minutes for BAC.

The goals of this study were to understand the implications of antibiotic and microbicideresistance among A. baumannii isolates and to assess their potential contribution to hospital outbreaks. We selected disinfecting wipes and skin antiseptics that are routinely used in Cooper University Hospital. We showed that all wipe formulations were effective disinfectants against free-living, planktonic A. baumannii strains at 1, 2, and 4 min. Since we tested five different hospital wipes and two skin antiseptics, we compared the efficacy of these different microbicides. We found that povidone, CHG, and the QACs killed 100% of planktonic bacteria. However, following exposure to 0.63% bleach, 55% ethanol, and 70% ethanol at their proper dwell times, a small subpopulation (<0.1%) of bacteria repeatedly survived. For disinfectants to properly destroy pathogens, they must be used at the proper dwell time. The standard dwell times for DDAC against A. baumannii is 1 min and 2 min for BAC [46, 47] . Bleach is a disinfectant at 1 min, but sterilizes at 4 min, and common hospital practice recommends using a contact time of 4 min [44] . 50% ethanol is generally germicidal after 60 s and 70% ethanol is germicidal after 30 s [45] . Even at an extended dwell time of 4 min, we found that a small subpopulation remained (Figure 1 and Table S2 ). This suggests that in any population of A. baumannii, microbicide-tolerant persisters may exist, even if the strains were not exposed to these agents prior. Bacterial persistence is a commonly observed phenomenon during drug exposure and is believed to be a factor in recurring bacterial infections [58, 59] . Recently, bacterial persisters were found in Escherichia coli in response to QACs [60] . It is possible that these persisters contribute to the spread of A. baumannii infections in hospital settings, as these bacteria survive well on hard surfaces [4, 12, [20] [21] [22] [23] [24] [25] . These results were obtained following proper dwell times, so this may become even more significant if improper disinfecting techniques are used.

Antibiotic resistance is selected for when a subpopulation of bacteria survives exposure to a drug, likely by upregulating efflux pumps or obtaining additional resistance genes through plasmid exchange [61] . A similar phenomenon likely exists for microbicide tolerance or resistance. We hypothesized that MDR strains either more easily acquire additional determinants that confer microbicide resistance or contain drug-resistance determinants that confer cross-protection against microbicides. We expected that the MDR strains would be more resistant to some microbicides than PS strains. While we did not find any differences in the percentage of survival between MDR and PS strains during the time-kill assays with bleach (Figure 2 ), the MDR strains had a higher average MBC. With a higher MBC, this made the MBC/MIC ratio >4, indicating that bleach is not bactericidal against these strains, but is bacteriostatic (Table 2 ). This was also true for the microbicide-resistant strains. The MDR strains also had an increased MBC to ethanol (Table 3) , whereas the microbicideresistant strains had an increased MBC in isopropanol (Table 4 ), but both these agents were still bactericidal. The increase in MBC indicates an evolutionary trend and may imply that upon further exposure to the microbicide, it is more likely that they will develop increased tolerance or resistance [41] . These findings highlight the importance of using antiseptics well above the MIC or MBC to ensure proper disinfection [62] . It is also important to note that we only evaluated ten strains; future studies should evaluate more strains to better understand the relationship between antibiotic and microbicidal-resistance genes.

The relationship between microbicidal and drug-resistance is equivocal. Even though some studies identified the presence of microbicidal-resistance genes in MDR pathogens [5, 34, 36, 39] , evidence of phenotypic resistance has not been demonstrated in vitro [39, 40] . On the other hand, some research has been able to demonstrate such a relationship [42] . It is likely that microbicide tolerance, rather than antibiotic resistance is the significant driver determining bacterial survival in adverse environments [5, 32, 35, 37, 42] . We screened our collection for several known microbicidal-resistance genes from the SMR family that included the common efflux pump genes qacA, qacE, and qacE∆1, and cepA. The qac resistance genes confer resistance to quaternary ammonium compounds, such as BAC and DDAC [35] . They also can confer resistance to specific antimicrobials, such as qacE with sulfonamides [35] and cepA with CHG [5, 32, 37] . Our data does not demonstrate a relationship between the two types of resistance, as microbicidal-resistance gene distribution in our strain collection was not associated with antimicrobial resistance (Table 1) . Only one MDR strain in our collection had the three microbicide-resistance genes whereas and all others were PS. It is possible that MDR strains continue to acquire additional microbicidal-resistance genes during the evolution of a prolonged hospital outbreak. Of course, it is also possible that there are additional, uncharacterized resistance mechanisms in our collection. In addition, we do not know which efflux systems are expressed in these strains, if any. While there was no planktonic bacterial survival after QAC, povidone or CHG exposure among microbicide-resistant strains, there was a significant increase in bacterial survival after bleach treatment compared to microbicide-susceptible strains (Figure 3 ). This suggests that some of these efflux pumps may be expressed and that their expression confers more tolerance to bleach exposure.

As we did not observe differences among free-living MDR and PS bacteria, we thought that differences might emerge following biofilm growth. The bacterial biofilm encases the cells an extracellular matrix that protects cells in vivo from immune defenses and antibiotics, and protects them from environmental insults such as surface disinfectants [63, 64] . In the natural environment, the ability to form biofilms is critical for A. baumannii survival [65] . We assessed microbicide efficacy against A. baumannii following biofilm formation. We found that larger percentages of the population survived, when compared to free-living bacteria. On average, 3.7%, 5.6%, 0.9%, 1.5%, and 2.6% of bacteria survived after exposure to 4 min of bleach, 1 min of 55% ethanol, 1 min of 70% ethanol, 2 min of 0.5% BAC, and 1 min of 0.61% DDAC, respectively (Table S3) . Again, increasing the exposure time did not result in an increase in bacterial killing (Table S4) . Rather, we observed that longer exposure to 70% ethanol and 0.61% DDAC resulted in statistically significant more bacterial survival compared to the 1-min time point. The small observed increase in survival is likely not biologically relevant. In addition, no differences were observed between MDR and PS strains (Figure 6 ), however differences were seen between microbicide-resistant and sensitive strains (Figure 7) , suggesting that drug resistance is a separate phenomenon from microbicide resistance. This data suggests that the surviving subpopulation is tolerant or resistant to these microbicidal agents. Similar to a prior study which highlighted the connection between biofilm formation and antiseptic resistance [28] , our findings of bacterial survival of >0.1% demonstrate that biofilm formation is an innate mechanism of microbicide tolerance. Together, our results suggest the need for a more extensive decontamination process when biofilms might be involved. For instance, a previous study demonstrated that it took up to 10 min to destroy A. baumannii biofilms [66] . Furthermore, if there is extensive grime or other visible soil, additional wipes and pre-cleaning with applied friction is recommended for disinfection [44, 46, 47] . Our findings, along with prior studies suggest that bacterial biofilms may require pre-cleaning prior to disinfection. As it is difficult to know when bacterial biofilms are present, the safest option is to implement a pre-cleaning step with use of friction as part of standard hospital operating procedures.

In sum, a more holistic approach that extends beyond surface decontamination may be needed to combat HAI's. Surfaces in hospitals and health care facilities serve as reservoirs for pathogens, and hands are usually the vector transferring those microorganisms to patients. Thus, hand hygiene is important in minimizing transfer of pathogens. Cleaning and disinfecting the environment where the patient resides is fundamental to reduce the microorganism burden in patient's environment. Most, if not all housekeeping surfaces need to be cleaned with soapy water or a detergent disinfectant, according to product specifications, where an emphasis is placed on scheduling and the technique used to clean and disinfect [67, 68] . In addition, to focus on the environmental surfaces, there has been heavy reliance on development of strategies to prevent HAIs, often referred to as "bundles" of infection prevention. A method called the "bundle" approach consists of ongoing hospital staff education with regards to maintaining strict hand hygiene, isolation precautions, environmental cleaning, and surveillance of high-risk areas. In 2009, a hospital in Spain assessed the long-term impact of the bundle approach from 1994 to 2003. Results showed that the rates of colonization and infection significantly decreased from 0.82 cases per 100 admissions in 1994, to 0. 46 in 1996-1997, to 0.21 in 1998-2003 [69] . Thus, while proper decontamination is important, a multi-disciplinary approach is essential when attempting to combat this problematic pathogen.

Ten A. baumannii patient isolates were collected during a routine workup performed by the clinical microbiology lab at Cooper University Hospital, Camden, NJ, USA. The isolates were collected during a hospital outbreak from 2004-2005 and included strains from sporadic cases from 2007-2012. The bacterial isolates were de-identified of all patient information. Since the goals of the project did not include interactions or interventions with living individuals or their private identifiable data, the Cooper Human Research Protection Program determined that this project did not involve human subjects, and as a result, the present research did not require an IRB review. We selected five MDR and five PS strains, as determined by the susceptibility testing during routine workup. Liquid and agar Mueller-Hinton broth (MHB) and Luria broth (LB) were prepared following standard protocols. For time-kill assays with planktonic bacteria, cells were grown overnight in liquid MHB at 37 • C with aeration. For biofilm assays, starter cultures were grown overnight in liquid LB at 37 • C with aeration. Growth was monitored by measuring the optical density at 600 nm (OD 600 ) when appropriate.

Bacterial strains were grown overnight in MHB at 37 • C with aeration. The following day, 100 µL of stationary phase cells were added to 900 µL of diluted antiseptic in MHB, or MHB alone. The following commonly used hospital disinfectant wipes were recreated as solutions: 55% and 70% ethanol, 0.63% bleach, and two high alcohol QAC's: (1) 0.61% dodecyl dimethyl ammonium chloride (Millipore Sigma, Burlington, MA, USA) in 27% ethanol and 25% isopropanol, and (2) a combination of 0.25% alkyl dimethyl ethyl benzyl ammonium chloride (Millipore Sigma) and 0.25% alkyl dimethyl benzyl ammonium chloride (Beantown Chemical, Hudson, NH, USA) in 55% isopropanol. Skin antiseptics tested were 2% chlorohexidine gluconate (ThermoFisher Scientific, Waltham, MA, USA), and 10% povidone (ThermoFisher Scientific). The cells were incubated in the presence or absence of microbicides for 1, 2 and 4 min. At each time point, cells were centrifuged, washed twice with phosphate buffered saline (PBS, 10 mM potassium phosphate, pH 7.4, 0.15 M NaCl) and resuspended in 1 mL PBS. Serial dilutions were performed, plated on LB and incubated overnight at 37 • C. Prior to antiseptic treatment, cells were serially diluted and plated to determine initial culture counts. The next day, colony-forming units (CFUs) were counted for each time point, and percent survival determined as antiseptic-resistant CFUs/mL divided by the initial CFUs/mL. Experiments were performed in triplicate if some bacterial survival was noted or in duplicate if there was no bacterial survival (i.e., povidone, CHG, and QAC's).

Bacterial biofilms were grown as previously described [70] . Briefly, overnight cultures were diluted into fresh LB media at a starting OD 600 of 0.1. 200 µL of these solutions were added to a flat-bottomed 96-well plate and grown for 48 h to allow for biofilm formation. Following incubation, non-adherent bacteria were removed by washing three times with an equal volume of PBS. Four wells were used for each strain. MHB alone served as a sterility control. The other three wells were incubated in the presence of an antiseptic for 1, 2 and 4 min. The antiseptics tested were 0.63% bleach, 55% and 70% ethanol, 0.61% DDAC [46] , and 0.50% BAC [47] . The wells were washed three times with 100 µL PBS. To estimate survival of cells in the biofilm, XTT reduction assays were performed as described, with minor modifications [71] . A stock solution of 1 mg/mL XTT (Alfa Aesar, Tweksbury, MA, USA) was made in PBS, which required heating to~50 • C to fully dissolve the XTT. A 0.4 mM stock solution of menadione (MP Biomedicals) was made in dimethyl-formamide (DMF). Both solutions were filter sterilized with a 0.22 µM filter. To make a working solution, 1.5 mL of the XTT stock solution was mixed with 300 µL of the menadione stock solution. To each well, 200 µL of PBS and 12 µL of the XTT-menadione working solution was added. The plates were wrapped in foil and incubated overnight at 37 • C. The OD 450 was measured the following day, using a Synergy H1 Microplate reader (Biotek). Prior to analysis, the background was subtracted from each reading. Each experiment was performed three independent times.

Colony PCR was performed to detect the presence of the known microbicide-resistance genes qacA, qacE, qacE∆1, and cepA. The primers used for amplification are listed in Table 5 , and conditions used for the reaction were as previously described [5] . The PCR products were resolved on a 1% TAE agarose gel, and bands visualized with EZ Vision dye (Avantor). All PCR reactions were performed two independent times. 

The MICs to the microbicides were determined by broth microdilution assay, according to standard protocols [72] . The OD 600 of overnight cultures were determined, and cells diluted to a starting OD 600 of 0.05. The starting concentration ("X") for each antiseptic agent is listed in Table 6 . Each antiseptic was added at a 2X concentration to the first column of a 96-well plate. Two-fold serial dilutions were performed, and an equal volume of diluted cells was added to each well. The plates were incubated overnight at 37 • C without shaking. The following day, the OD 600 values were read using a Synergy H1 Microplate reader (Biotek). All MIC determinations were made at least two independent times. To determine MBCs, 25 µL of cells from each well where no growth was observed were plated on LB. Plates were incubated overnight at 37 • C, and following incubation, plates were observed for bacterial growth. The lowest concentration where no growth was observed, was reported as the MBC. All determinations were made at least two independent times. 

Statistical analyses were performed using GraphPad Prism 9. The DUOT outlier test was performed on replicates and removed 5% of outliers. If outliers were removed, the experiment was repeated to produce at least three, biological replicates. For statistical comparisons, strains were grouped based on resistance patterns, i.e., MDR vs. PS and presence of multiple microbicide-resistance genes (microbicide-resistant, cepA, qacE, and qacE∆1) vs. cepA alone (microbicide-sensitive), for both planktonic and biofilms conditions. One factor ANOVAs with post-hoc Tukey tests were performed to evaluate whether the type of bacterial resistance affected bacterial survival with varying dwell times or varying types of microbicides at proper dwell time. Unpaired t-tests were used to compare MDR and PS strains, and microbicide-resistant and microbicide-sensitive strains for each microbicide. A p value ≤ 0.05 was considered statistically significant.

Our findings highlight that antibiotic resistance may occur by mechanisms other than microbicidal resistance and may be expressed independently in some MDR strains. Microbicide-resistance genes were not necessarily associated with MDR strains, as in our collection, it was more likely that the PS strains contained such resistance genes. The presence of such genes does not mean that they are expressed; however, there was increased survival among planktonic bacteria to some antiseptic agents in the presence of these genes, suggesting that one or more might be expressed. Currently, some hospital policies require isolation precautions only if the pathogen is MDR. Given our findings of microbicide resistance even amongst PS strains, hospitals may want to consider stricter contact precautions, even among infections with PS A. baumannii. In addition, while the 0.1% surviving subpopulation represents a small number of bacteria in the population, they may still contribute to hospital outbreaks. It is important to note that our study only evaluated 10 strains, and thus, is a work in progress, requiring further study with a larger sample size to properly evaluate the clinical significance of this subpopulation's role in perpetuating hospital outbreaks. Finally, and perhaps more pertinent to microbicide resistance, when biofilm formation occurred, a noticeable reduction in disinfectant effectiveness was observed. Therefore, the main form of microbicide tolerance may be due to biofilm formation rather than the expression of microbicide-resistance genes. However, these possibilities are not mutually exclusive, and it may be that the combination of specific resistance genes in bacteria that readily form biofilms is the most problematic in terms of their removal from hospital surfaces. This highlights the need for more thorough decontamination processes that include pre-cleaning in addition to disinfection.

The following supporting information can be downloaded at: https: //www.mdpi.com/article/10.3390/antibiotics11050614/s1, Table S1 : Percent survival of planktonic bacteria following microbicide exposure at proper contact times, Table S2 : Average survival following microbicide exposure of planktonic bacteria, Table S3 : Percent survival of bacterial biofilms following microbicide exposure at proper contact times and Table S4 : Average survival following microbicide exposure of bacterial biofilms. 

Resistant Gram-negative infections

Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization

Attributable mortality of healthcare-associated infections due to multidrug-resistant Gram-negative bacteria and methicillin-resistant Staphylococcus aureus

Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features

High Prevalence of blaNDM-1, blaVIM, qacE, and qacE∆1 genes and their association with decreased susceptibility to antibiotics and common hospital biocides in clinical isolates of Acinetobacter baumannii

Biggest Threats and Data Antibiotic/Antimicrobial Resistance CDC

The Sanford Guide to Antimicrobial Therapy

Molecular mechanisms of antimicrobial resistance in Acinetobacter baumannii, with a special focus on its epidemiology in Lebanon

The battle is on: New beta-lactams for the treatment of multidrug-resistant Gram-negative organisms

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): A randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial

Structured patient interview to assess clinical outcomes in complicated urinary tract infections in the APEKS-cUTI study: Pilot investigation

The epidemiology and control of Acinetobacter baumannii in health care facilities

Gram-negative Surveillance Initiative

Acinetobacter in Healthcare Settings HAI CDC. Available online

Carbapenem-resistant Acinetobacter baumannii: In pursuit of an effective treatment

The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis

Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients

Ventilator-associated pneumonia

Multidrug resistance, inappropriate empiric therapy, and hospital mortality in Acinetobacter baumannii pneumonia and sepsis

Multiple heavy metal and antibiotic resistance of Acinetobacter baumannii strain HAF-13 isolated from industrial effluents

Acinetobacter spp. in food and drinking water-A review

Extensively and multi drug-resistant Acinetobacter baumannii recovered from technosol at a dump site in Croatia

Characterization of Acinetobacter baumannii from water and sludge line of secondary wastewater treatment plant

Analysis of Acinetobacter baumannii survival in liquid media and on solid matrices as well as effect of disinfectants

Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases

Glossary Disinfection & Sterilization Guidelines Library Infection Control CDC

Correlation between reduced susceptibility to disinfectants and multidrug resistance among clinical isolates of Acinetobacter species

Reduced susceptibility to disinfectants of Acinetobacter baumannii biofilms on glass and ceramic

Biofilm formation in Acinetobacter baumannii: Genotype-phenotype correlation

Biogenic silver nanoparticles: Synthesis and application as antibacterial and antifungal agents

Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii

Antiseptics and disinfectants: Activity, action, and resistance

Biological activity of quaternary ammonium salts and their derivatives

Biocide resistance in Acinetobacter baumannii: Appraising the mechanisms

Efflux-mediated antibiotic resistance in Acinetobacter spp

Molecular characterization of reduced susceptibility to biocides in clinical isolates of Acinetobacter baumannii

Cloning of a cation efflux pump gene associated with chlorhexidine resistance in Klebsiella pneumoniae

Extremely high prevalence of antiseptic resistant quaternary ammonium compound E gene among clinical isolates of multiple drug resistant Acinetobacter baumannii in Malaysia

Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii-A first report from the Kingdom of Saudi Arabia

Resistance pattern and distribution of carbapenemase and antiseptic resistance genes among multidrug-resistant Acinetobacter baumannii isolated from intensive care unit patients

Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii

Reduced susceptibility to biocides in Acinetobacter baumannii: Association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps

Product Performance Test Guidelines: OCSPP 810.2300 Sanitizers for Use on Hard Surfaces-Efficacy Data Recommendations

Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs

Pesticide Product Label, Wonder Woman Formula B Germicidal Disposable Cloth

US EPA Office of Pesticide Programs, US EPA. Pesticide Product Label, SANI-CLOTH GERMICIDAL WIPES

Pharmacodynamics of antimicrobial drugs

Development of a protocol for predicting bacterial resistance to microbicides

Acinetobacter baumannii biofilms: Effects of physicochemical factors, virulence, antibiotic resistance determinants, gene regulation, and future antimicrobial treatments

Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces

Uncovering the mechanisms of Acinetobacter baumannii virulence

Division of Infectious Diseases, Department of Medicine

High rate of multidrug-resistant organisms (MDROs) among COVID-19 patients presenting with bacteremia upon hospital admission

Increased use of antibiotics in the intensive care unit during coronavirus disease (COVID-19) pandemic in a brazilian hospital

Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions-New Jersey

Persistent bacterial infections and persister cells

Mechanisms of bacterial tolerance and persistence in the gastrointestinal and respiratory environments

Persistence against benzalkonium chloride promotes rapid evolution of tolerance during periodic disinfection

Bacterial resistance to antimicrobial agents

Mechanisms of antimicrobial action of antiseptics and disinfectants: An increasingly important area of investigation

Antimicrobial tolerance in biofilms

Microbial biofilm: Current challenges in healthcare industry

The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii

Desiccation and ethanol resistances of multidrug resistant Acinetobacter baumannii embedded in biofilm: The favorable antiseptic efficacy of combination chlorhexidine gluconate and ethanol

Relation of the inanimate hospital environment to endemic nosocomial infection

Nosocomial infections on nursing units with floors cleaned with a disinfectant compared with detergent

Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive "bundle" approach

Growth rate and biofilm formation ability of clinical and laboratory-evolved colistin-resistant strains of Acinetobacter baumannii

Crystal violet and XTT assays on Staphylococcus aureus biofilm quantification

Determination of minimum inhibitory concentrations

We thank Dejan Nikolic for performing mass spectrometry experiments on the collection to confirm the species and for providing susceptibility data.

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.Antibiotics 2022, 11, 614